Evogene braces for proxy fight with massive share authorization and reverse split on the table
EVGN sits 27% above its 52-week low of $0.37.
Summary
Evogene's proxy filing reveals a high-stakes board battle with activist shareholders, alongside proposals for a massive share authorization increase and a reverse split. The September 4 meeting will decide control of the company.
Key Events · Corporate Governance and Compliance · EVGN
-
Contested Board Election
Shareholders will choose between the Evogene Slate of 7 directors and the Pure Capital Slate of 4 directors, nominated by activists holding 17.41%. The winning slate takes full control.
-
Massive Authorized Share Increase Proposed
Proposal 2 seeks to boost authorized shares from 30M to 150M — a 400% increase — to provide flexibility for Nasdaq compliance, strategic transactions, and general corporate purposes.
-
Reverse Split Framework Sought
Proposal 3 asks for authority to implement a reverse split between 1-for-2 and 1-for-15 within 18 months, primarily to regain Nasdaq's $1 minimum bid price compliance by the September 28 deadline.
-
Executive Departure
VP Business Development Olga Nissan stepped down effective July 31, 2026. A replacement search is underway.
Analysis · EVGN · Industrial Applications And Services
A contested election looms as Evogene's board faces an activist group that already holds 17.41% and has been accumulating more shares. At the same time, shareholders are being asked to approve a 400% increase in authorized shares and a reverse split framework — tools that could serve either to fend off the activists or to raise dilutive capital. The September 4 vote will determine who controls the company and its strategic direction, while the departure of the VP of Business Development adds further uncertainty.
At the time of this filing, EVGN was trading at $0.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.9M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.